| Primary |
| Type 2 Diabetes Mellitus |
37.3% |
| Gestational Diabetes |
20.9% |
| Diabetes Mellitus |
14.9% |
| Product Used For Unknown Indication |
9.0% |
| Diabetes Mellitus Insulin-dependent |
3.0% |
| Injection Site Reaction |
3.0% |
| Osteoporosis |
3.0% |
| Type 1 Diabetes Mellitus |
3.0% |
| Blood Glucose Increased |
1.5% |
| Hypertension |
1.5% |
| Migraine |
1.5% |
| Pneumonia |
1.5% |
|
| Pneumonia |
12.5% |
| Foetal Exposure During Pregnancy |
8.3% |
| Oedema |
8.3% |
| Cardiac Hypertrophy |
4.2% |
| Dermatitis Exfoliative |
4.2% |
| Exposure During Pregnancy |
4.2% |
| Foetal Growth Restriction |
4.2% |
| Headache |
4.2% |
| Heparin-induced Thrombocytopenia |
4.2% |
| Hypersensitivity |
4.2% |
| Hypoglycaemia |
4.2% |
| Hypoglycaemic Coma |
4.2% |
| Ketoacidosis |
4.2% |
| Maternal Exposure During Pregnancy |
4.2% |
| Microsomia |
4.2% |
| Monoparesis |
4.2% |
| Myocardial Ischaemia |
4.2% |
| Painful Respiration |
4.2% |
| Palpitations |
4.2% |
| Polyneuropathy |
4.2% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
33.3% |
| Diabetes Mellitus |
17.4% |
| Gestational Diabetes |
10.1% |
| Hypertension |
7.8% |
| Product Used For Unknown Indication |
7.4% |
| Diabetes Mellitus Insulin-dependent |
5.8% |
| Drug Use For Unknown Indication |
3.9% |
| Osteoporosis |
2.7% |
| Coronary Artery Disease |
1.9% |
| Dyslipidaemia |
1.6% |
| Acute Coronary Syndrome |
1.2% |
| Type Ii Diabetes Mellitus |
1.2% |
| Anticoagulant Therapy |
0.8% |
| Arrhythmia |
0.8% |
| Gastroenteritis |
0.8% |
| Gout |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Injection Site Reaction |
0.8% |
| Type 1 Diabetes Mellitus |
0.8% |
| Diabetes |
0.4% |
|
| Foetal Death |
15.7% |
| Nausea |
7.8% |
| Premature Baby |
7.8% |
| Ascites |
5.9% |
| Foetal Growth Restriction |
5.9% |
| Haematuria |
5.9% |
| Headache |
5.9% |
| Death |
3.9% |
| Epilepsy |
3.9% |
| Hyperlipasaemia |
3.9% |
| Injection Site Atrophy |
3.9% |
| Maternal Exposure Timing Unspecified |
3.9% |
| Pancreatitis Acute |
3.9% |
| Pneumonia |
3.9% |
| Pulmonary Malformation |
3.9% |
| Ventricular Fibrillation |
3.9% |
| Weight Increased |
3.9% |
| Abdominal Pain |
2.0% |
| Altered State Of Consciousness |
2.0% |
| Arrhythmia |
2.0% |
|
| Concomitant |
| Diabetes Mellitus |
15.3% |
| Product Used For Unknown Indication |
15.3% |
| Drug Use For Unknown Indication |
6.3% |
| Type 2 Diabetes Mellitus |
6.3% |
| Insulin-requiring Type Ii Diabetes Mellitus |
5.9% |
| Hypertension |
5.7% |
| Pain |
5.1% |
| Renal Transplant |
4.5% |
| Depression |
3.9% |
| Prophylaxis |
3.9% |
| Diabetes Mellitus Insulin-dependent |
3.7% |
| Hiv Infection |
3.5% |
| Multiple Myeloma |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Type 1 Diabetes Mellitus |
2.9% |
| Osteoporosis |
2.5% |
| Maternal Exposure During Pregnancy |
2.2% |
| Prophylaxis Against Transplant Rejection |
2.2% |
| Transplant Rejection |
2.2% |
| Stent Placement |
2.0% |
|
| Fluid Retention |
8.3% |
| Vomiting |
8.3% |
| White Blood Cell Count Decreased |
8.3% |
| Myocardial Infarction |
7.1% |
| Hypoglycaemia |
6.0% |
| Syncope |
6.0% |
| Pneumonia |
4.8% |
| Renal Failure |
4.8% |
| Renal Failure Acute |
4.8% |
| Respiratory Tract Infection |
4.8% |
| Supraventricular Tachycardia |
4.8% |
| Anaemia |
3.6% |
| Atypical Femur Fracture |
3.6% |
| Constipation |
3.6% |
| Dyspnoea |
3.6% |
| Liver Disorder |
3.6% |
| Loss Of Consciousness |
3.6% |
| Lower Respiratory Tract Infection |
3.6% |
| Lymphoma |
3.6% |
| Oesophagitis |
3.6% |
|
